Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells.

Area of Science:

• Stem Cell Biology
• Neuroscience
• Regenerative Medicine

Background:

• Human pluripotent stem cells (hPSCs) are crucial for regenerative medicine and modeling intractable disorders.
• Disease-specific induced pluripotent stem cells (hiPSCs) from patients enable in vitro modeling of neurological conditions.
• Neural cells derived from hiPSCs are vital for studying pathogenesis when direct patient cell access is limited.

Purpose of the Study:

• To establish a rapid, efficient, and simple method for deriving motor neurons from hPSCs.
• To develop a tool for pathophysiological analysis and drug development for motor neuron diseases.
• To create a reproducible system minimizing clonal variation for hiPSC-derived motor neurons.

Main Methods:

• Utilized GSK3β inhibitors and dual SMAD inhibition for neural progenitor induction within one week.
• Employed retinoic acid (RA) and purmorphamine to efficiently induce motor neurons within two weeks.
• Established a lentiviral reporter system (HB9::Venus) for visualizing and analyzing motor neurons.

Main Results:

• Achieved highly efficient induction of HB9(+) and ISL-1(+) motor neurons from hPSCs.
• Demonstrated maturation of hPSC-derived motor neurons, evidenced by larger somas and ChAT expression.
• Confirmed functional neuromuscular junctions and acetylcholine receptor clustering in vitro, indicating functional synaptic connections.
• Validated the HB9 reporter system's specificity using FACS and quantitative RT-PCR.

Conclusions:

• The developed motor neuron differentiation system provides a robust platform for studying motor neuron diseases.
• The lentivirus-based reporter system facilitates specific analysis of motor neurons derived from disease-specific hiPSCs.
• This methodology supports advancements in understanding motor neuron diseases and therapeutic development.